Najib Ben Khaled

16PUBLICATIONS
101CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 06, 2026
Circulating extracellular vesicles carrying PD-1, PD-L1 and CTLA-4 inform resistance to anti-PD-L1-based therapy in HCC.

|Jul 03, 2026
Dysregulated sphingolipid metabolismdrives pancreatic carcinogenesis through plasma membrane Kras enrichment.

|May 19, 2026
Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma-Data From the Multinational LITCHI Registry.

|Feb 24, 2026
Sequential or upfront triple combination with durvalumab, tremelimumab, and bevacizumab for patients with unresectable hepatocellular carcinoma: the MONTBLANC trial protocol (AIO-HEP-0325/ass).

Najib Ben Khaled, Ursula Ehmer, Ilja Kubisch

|Oct 27, 2025
Treatment gaps and survival outcomes of hepatocellular carcinoma: insights from a nationwide, claims-based study.

Simone Schrodi, Karin Berger-Thürmel, Selina Becht

|Apr 04, 2025
Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real-World Analysis of the IMMUreal Cohort.

Najib Ben Khaled, Valentina Zarka, Bernard Hobeika

Pageof 3

Frequent Collaborators

10 joint publications

Enrico N De Toni

5 joint publications

Matthias Pinter

4 joint publications

Marino Venerito

4 joint publications

Bernhard Scheiner